US Stock MarketDetailed Quotes

EXAS Exact Sciences

Watchlist
  • 46.360
  • +1.520+3.39%
Close Jul 12 16:00 ET
  • 47.000
  • +0.640+1.38%
Post 18:40 ET
8.55BMarket Cap-35389P/E (TTM)

Exact Sciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
5.82%637.52M
19.93%2.5B
16.98%646.89M
20.12%628.34M
19.26%622.09M
23.82%602.45M
17.95%2.08B
16.71%553M
14.61%523.07M
19.97%521.64M
Operating revenue
5.82%637.52M
19.93%2.5B
16.98%646.89M
20.12%628.34M
19.26%622.09M
23.82%602.45M
17.95%2.08B
16.71%553M
14.61%523.07M
19.97%521.64M
Cost of revenue
8.41%170.1M
13.89%654.2M
16.76%171.82M
13.92%168.53M
8.58%157M
16.48%156.9M
25.21%574.4M
23.60%147.16M
27.86%147.94M
26.84%144.6M
Gross profit
4.91%467.42M
22.23%1.85B
17.06%475.07M
22.57%459.81M
23.35%465.09M
26.62%445.55M
15.41%1.51B
14.40%405.84M
10.11%375.14M
17.52%377.04M
Operating expense
9.00%569.69M
-1.32%2.06B
4.14%542.87M
-10.70%452.96M
2.17%541.52M
-1.18%522.65M
-2.63%2.09B
-9.53%521.28M
5.15%507.25M
7.63%530.04M
Selling and administrative expenses
7.72%435.5M
2.34%1.62B
1.72%411.03M
2.87%390.55M
4.25%414.5M
0.57%404.3M
-4.80%1.58B
-12.85%404.09M
-0.90%379.67M
9.71%397.6M
-Selling and marketing expense
-4.91%50.4M
-29.57%203.9M
-22.91%57.59M
-33.54%43.86M
-32.01%49.5M
-30.35%53M
-66.41%289.5M
-88.88%74.7M
-0.91%66M
10.81%72.8M
-General and administrative expense
9.62%385.1M
9.48%1.42B
7.30%353.45M
10.53%346.69M
12.38%365M
7.79%351.3M
61.47%1.29B
258.33%329.39M
-0.89%313.67M
9.47%324.8M
Research and development costs
15.92%110.61M
8.25%425.88M
21.90%114.92M
22.72%111.45M
-1.87%104.1M
-6.68%95.42M
2.02%393.42M
6.54%94.27M
20.51%90.81M
-0.14%106.08M
Depreciation amortization depletion
1.67%23.31M
-5.43%92.16M
1.73%23.31M
-2.27%22.99M
-13.00%22.93M
-7.00%22.93M
2.58%97.45M
-4.71%22.91M
-1.73%23.53M
10.63%26.36M
-Depreciation and amortization
1.67%23.31M
-5.43%92.16M
1.73%23.31M
-2.27%22.99M
-13.00%22.93M
-7.00%22.93M
2.58%97.45M
-4.71%22.91M
-1.73%23.53M
10.63%26.36M
Other operating expenses
--268K
-692.17%-78.43M
---6.4M
-643.85%-72.03M
----
----
--13.24M
--0
--13.24M
----
Operating profit
-32.64%-102.26M
62.89%-214.35M
41.27%-67.8M
105.18%6.85M
50.04%-76.43M
56.45%-77.1M
30.87%-577.53M
47.87%-115.44M
6.78%-132.11M
10.86%-153M
Net non-operating interest income expense
-293.40%-7.94M
-51.63%-29.77M
-45.38%-7.87M
-50.35%-7.87M
-73.31%-7.82M
202.29%4.11M
-5.53%-19.63M
-16.14%-5.41M
-11.86%-5.24M
3.03%-4.51M
Non-operating interest income
----
----
----
----
----
--4.11M
----
----
----
----
Non-operating interest expense
--7.94M
75.60%24.42M
64.76%6.54M
72.57%6.54M
73.31%7.82M
----
7.98%13.91M
23.39%3.97M
17.15%3.79M
39.92%4.51M
Total other finance cost
----
-6.58%5.35M
-7.90%1.33M
-7.96%1.33M
----
----
0.00%5.73M
0.00%1.44M
0.00%1.44M
----
Other net income (expense)
319.71%1.77M
219.84%42.42M
379.36%25.33M
114.21%2.07M
141.47%4.28M
128.31%421K
-405.96%-35.39M
-823.05%-9.07M
40.21%-14.53M
-400.67%-10.31M
Gain on sale of security
1,167.96%6.21M
268.41%32.71M
549.51%25.33M
124.06%2.07M
229.82%4.83M
132.95%490K
-161.13%-19.43M
-549.36%-5.64M
-109.72%-8.58M
-208.46%-3.72M
Special income (charges)
-6,343.48%-4.45M
160.76%9.7M
--0
--0
91.62%-552K
---69K
20.98%-15.97M
---3.43M
70.58%-5.95M
---6.59M
-Less:Impairment of capital assets
6,343.48%4.45M
-96.11%621K
--0
--0
-91.62%552K
--69K
-20.98%15.97M
--3.43M
-70.58%5.95M
--6.59M
-Less:Other special charges
----
---10.32M
--0
----
----
----
----
----
----
----
Income before tax
-49.56%-108.42M
68.11%-201.75M
61.23%-50.38M
100.69%1.04M
52.38%-79.92M
60.38%-72.49M
24.92%-632.57M
42.22%-129.93M
11.08%-151.88M
2.93%-167.81M
Income tax
8.99%1.81M
126.51%2.4M
72.04%-610K
107.99%249K
163.22%1.11M
182.23%1.66M
96.33%-9.06M
48.57%-2.18M
19.23%-3.12M
-143.50%-1.75M
Net income
-48.65%-110.23M
67.26%-204.15M
61.04%-49.77M
100.53%794K
51.21%-81.03M
59.02%-74.15M
-4.68%-623.51M
42.09%-127.75M
10.89%-148.76M
6.13%-166.06M
Net income continuous Operations
-48.65%-110.23M
67.26%-204.15M
61.04%-49.77M
100.53%794K
51.21%-81.03M
59.02%-74.15M
-4.68%-623.51M
42.09%-127.75M
10.89%-148.76M
6.13%-166.06M
Minority interest income
Net income attributable to the parent company
-48.65%-110.23M
67.26%-204.15M
61.04%-49.77M
100.53%794K
51.21%-81.03M
59.02%-74.15M
-4.68%-623.51M
42.09%-127.75M
10.89%-148.76M
6.13%-166.06M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-48.65%-110.23M
67.26%-204.15M
61.04%-49.77M
100.53%794K
51.21%-81.03M
59.02%-74.15M
-4.68%-623.51M
42.09%-127.75M
10.89%-148.76M
6.13%-166.06M
Basic earnings per share
-42.86%-0.6
68.08%-1.13
62.50%-0.27
100.52%0.0044
52.13%-0.45
59.62%-0.42
-1.72%-3.54
43.75%-0.72
13.40%-0.84
8.74%-0.94
Diluted earnings per share
-42.86%-0.6
68.08%-1.13
62.50%-0.27
100.51%0.0043
52.13%-0.45
59.62%-0.42
-1.72%-3.54
43.75%-0.72
13.40%-0.84
8.74%-0.94
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 5.82%637.52M19.93%2.5B16.98%646.89M20.12%628.34M19.26%622.09M23.82%602.45M17.95%2.08B16.71%553M14.61%523.07M19.97%521.64M
Operating revenue 5.82%637.52M19.93%2.5B16.98%646.89M20.12%628.34M19.26%622.09M23.82%602.45M17.95%2.08B16.71%553M14.61%523.07M19.97%521.64M
Cost of revenue 8.41%170.1M13.89%654.2M16.76%171.82M13.92%168.53M8.58%157M16.48%156.9M25.21%574.4M23.60%147.16M27.86%147.94M26.84%144.6M
Gross profit 4.91%467.42M22.23%1.85B17.06%475.07M22.57%459.81M23.35%465.09M26.62%445.55M15.41%1.51B14.40%405.84M10.11%375.14M17.52%377.04M
Operating expense 9.00%569.69M-1.32%2.06B4.14%542.87M-10.70%452.96M2.17%541.52M-1.18%522.65M-2.63%2.09B-9.53%521.28M5.15%507.25M7.63%530.04M
Selling and administrative expenses 7.72%435.5M2.34%1.62B1.72%411.03M2.87%390.55M4.25%414.5M0.57%404.3M-4.80%1.58B-12.85%404.09M-0.90%379.67M9.71%397.6M
-Selling and marketing expense -4.91%50.4M-29.57%203.9M-22.91%57.59M-33.54%43.86M-32.01%49.5M-30.35%53M-66.41%289.5M-88.88%74.7M-0.91%66M10.81%72.8M
-General and administrative expense 9.62%385.1M9.48%1.42B7.30%353.45M10.53%346.69M12.38%365M7.79%351.3M61.47%1.29B258.33%329.39M-0.89%313.67M9.47%324.8M
Research and development costs 15.92%110.61M8.25%425.88M21.90%114.92M22.72%111.45M-1.87%104.1M-6.68%95.42M2.02%393.42M6.54%94.27M20.51%90.81M-0.14%106.08M
Depreciation amortization depletion 1.67%23.31M-5.43%92.16M1.73%23.31M-2.27%22.99M-13.00%22.93M-7.00%22.93M2.58%97.45M-4.71%22.91M-1.73%23.53M10.63%26.36M
-Depreciation and amortization 1.67%23.31M-5.43%92.16M1.73%23.31M-2.27%22.99M-13.00%22.93M-7.00%22.93M2.58%97.45M-4.71%22.91M-1.73%23.53M10.63%26.36M
Other operating expenses --268K-692.17%-78.43M---6.4M-643.85%-72.03M----------13.24M--0--13.24M----
Operating profit -32.64%-102.26M62.89%-214.35M41.27%-67.8M105.18%6.85M50.04%-76.43M56.45%-77.1M30.87%-577.53M47.87%-115.44M6.78%-132.11M10.86%-153M
Net non-operating interest income expense -293.40%-7.94M-51.63%-29.77M-45.38%-7.87M-50.35%-7.87M-73.31%-7.82M202.29%4.11M-5.53%-19.63M-16.14%-5.41M-11.86%-5.24M3.03%-4.51M
Non-operating interest income ----------------------4.11M----------------
Non-operating interest expense --7.94M75.60%24.42M64.76%6.54M72.57%6.54M73.31%7.82M----7.98%13.91M23.39%3.97M17.15%3.79M39.92%4.51M
Total other finance cost -----6.58%5.35M-7.90%1.33M-7.96%1.33M--------0.00%5.73M0.00%1.44M0.00%1.44M----
Other net income (expense) 319.71%1.77M219.84%42.42M379.36%25.33M114.21%2.07M141.47%4.28M128.31%421K-405.96%-35.39M-823.05%-9.07M40.21%-14.53M-400.67%-10.31M
Gain on sale of security 1,167.96%6.21M268.41%32.71M549.51%25.33M124.06%2.07M229.82%4.83M132.95%490K-161.13%-19.43M-549.36%-5.64M-109.72%-8.58M-208.46%-3.72M
Special income (charges) -6,343.48%-4.45M160.76%9.7M--0--091.62%-552K---69K20.98%-15.97M---3.43M70.58%-5.95M---6.59M
-Less:Impairment of capital assets 6,343.48%4.45M-96.11%621K--0--0-91.62%552K--69K-20.98%15.97M--3.43M-70.58%5.95M--6.59M
-Less:Other special charges -------10.32M--0----------------------------
Income before tax -49.56%-108.42M68.11%-201.75M61.23%-50.38M100.69%1.04M52.38%-79.92M60.38%-72.49M24.92%-632.57M42.22%-129.93M11.08%-151.88M2.93%-167.81M
Income tax 8.99%1.81M126.51%2.4M72.04%-610K107.99%249K163.22%1.11M182.23%1.66M96.33%-9.06M48.57%-2.18M19.23%-3.12M-143.50%-1.75M
Net income -48.65%-110.23M67.26%-204.15M61.04%-49.77M100.53%794K51.21%-81.03M59.02%-74.15M-4.68%-623.51M42.09%-127.75M10.89%-148.76M6.13%-166.06M
Net income continuous Operations -48.65%-110.23M67.26%-204.15M61.04%-49.77M100.53%794K51.21%-81.03M59.02%-74.15M-4.68%-623.51M42.09%-127.75M10.89%-148.76M6.13%-166.06M
Minority interest income
Net income attributable to the parent company -48.65%-110.23M67.26%-204.15M61.04%-49.77M100.53%794K51.21%-81.03M59.02%-74.15M-4.68%-623.51M42.09%-127.75M10.89%-148.76M6.13%-166.06M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -48.65%-110.23M67.26%-204.15M61.04%-49.77M100.53%794K51.21%-81.03M59.02%-74.15M-4.68%-623.51M42.09%-127.75M10.89%-148.76M6.13%-166.06M
Basic earnings per share -42.86%-0.668.08%-1.1362.50%-0.27100.52%0.004452.13%-0.4559.62%-0.42-1.72%-3.5443.75%-0.7213.40%-0.848.74%-0.94
Diluted earnings per share -42.86%-0.668.08%-1.1362.50%-0.27100.51%0.004352.13%-0.4559.62%-0.42-1.72%-3.5443.75%-0.7213.40%-0.848.74%-0.94
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Cancer Research
Cancer Research
Intraday-0.05%